Microbiome revolution

Understanding the Microbiome

At YSOPIA Bioscience, we strongly believe that the gut microbiome – as it plays a crucial role in human health – is the next paradigm-shift in medicine and a tremendous hope for patients.

“The composition of the microbiome and its activities are involved in most, if not all, of the biological processes that constitute human health and disease.” M. J. Blaser in J. Clin. Invest. (2014). 

Microbiome is a “hidden organ” which controls our health. Bacteria shape their host and are precious partners, playing a central role in a myriad of essential functions in our body – such as metabolism, digestion, immune and neurological functions – through different pathways.

Our gut microbiome is like a virgin forest: a complex and diverse ecosystem which functions in symbiosis with our body. Our modern life, characterized by unhealthy diet, pollution, stress and chemical exposure, can strongly deteriorate this symbiosis. 

> Discover our pipeline

At the Root of Chronic Diseases

Countless studies have recently established the strong links between a disbalance of the microbiome and the development of chronic diseases. In this context, the best way to target the root causes of the disease is by treating this disbalance.

In today’s world, one in three adults suffer from multiple chronic conditions. There is an urgent need to better address chronic diseases.

Chronic diseases are complex and result from a combination of genetic, physiological, environmental and behavioural factors. Despite their complexity, they all share one common feature: an imbalance of microbiome, called dysbiosis, scientifically established as a cause of these diseases.

 

Microbiome & us
News
Dec 2, 2021
YSOPIA Bioscience Announces First Signs of Biological Activity from Phase I Analysis of Xla1, its Biotherapy Targeting...
> more
Nov 1, 2021
YSOPIA Bioscience Announces Leadership Team Reorganization and Appoints Co-Founder & CFO Fabrice Guez CEO & CFO...
> more
Press / Media
Sep 13, 2021
The European Medicines Agency (EMA) and the US Food and Drug Administration (FDA) apply an aligned and complimentary...
> more
Jun 16, 2021
Forte de la découverte de Christensenella, une bactérie naturellement présente dans les microbiotes sains, la...
> more
Publications
Nov 1, 2021
We are pleased to present our poster highlighting safety and first efficacy results of our Xla1 biotherapy targeting...
> more
Sep 1, 2021
Héloïse Tudela, Sandrine P. Claus and Maya Saleh Access the full paper The community of the diverse microorganisms...
> more
now on twitter
YSOPIA Bioscience

“This initial biological activity data, observed in a study initially focusing on the safety of our treatment, is m… t.co/nGX4rzEYtm

YSOPIA Bioscience © 2021 - all rights reserved terms and conditions